What happened to the principle of ‘do no harm’?
A drug with a controversial FDA approval, with a surrogate end-point because it failed to achieve its first, has been put on the back burner.
A drug with a controversial FDA approval, with a surrogate end-point because it failed to achieve its first, has been put on the back burner.
Copyright ©2024 Louise Morse | Website Design by Buchanan Solutions